Emi Shoji

808 total citations
8 papers, 636 citations indexed

About

Emi Shoji is a scholar working on Molecular Biology, Physiology and Biomedical Engineering. According to data from OpenAlex, Emi Shoji has authored 8 papers receiving a total of 636 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 2 papers in Physiology and 2 papers in Biomedical Engineering. Recurrent topics in Emi Shoji's work include Pluripotent Stem Cells Research (6 papers), CRISPR and Genetic Engineering (3 papers) and Muscle Physiology and Disorders (3 papers). Emi Shoji is often cited by papers focused on Pluripotent Stem Cells Research (6 papers), CRISPR and Genetic Engineering (3 papers) and Muscle Physiology and Disorders (3 papers). Emi Shoji collaborates with scholars based in Japan and Singapore. Emi Shoji's co-authors include Hidetoshi Sakurai, Atsuko Sehara‐Fujisawa, Knut Woltjen, Yasuko Manabe, Nobuharu Fujii, Kazunori Hanaoka, Masamichi Koike, Tsuyoshi Takeda, Hideharu Anazawa and Akeo Shinkai and has published in prestigious journals such as The Journal of Immunology, PLoS ONE and Scientific Reports.

In The Last Decade

Emi Shoji

8 papers receiving 626 citations

Peers

Countries citing papers authored by Emi Shoji

Since Specialization

Citations

This map shows the geographic impact of Emi Shoji's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emi Shoji with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emi Shoji more than expected).

Fields of papers citing papers by Emi Shoji

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emi Shoji. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emi Shoji. The network helps show where Emi Shoji may publish in the future.

Co-authorship network of co-authors of Emi Shoji

This figure shows the co-authorship network connecting the top 25 collaborators of Emi Shoji. A scholar is included among the top collaborators of Emi Shoji based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emi Shoji. Emi Shoji is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

#	Work	Indexed citations
1	Perception of Adherence to Daily Human Growth Hormone Treatments Among Pediatric and Adolescent Patients in Japan: A Cross-Sectional Survey of Physicians and Caregivers 2022 ·Patient Preference and Adherence ·Manabu Akazawa, Daisuke Shima, (unknown), Emi Shoji, (unknown), (unknown)	2
2	In Vitro Evaluation of Exon Skipping in Disease-Specific iPSC-Derived Myocytes 2018 ·Methods in molecular biology ·Mingming Zhao, Emi Shoji, Hidetoshi Sakurai	6
3	Directed Myogenic Differentiation of Human Induced Pluripotent Stem Cells 2015 ·Methods in molecular biology ·Emi Shoji, Knut Woltjen, Hidetoshi Sakurai	33
4	Early pathogenesis of Duchenne muscular dystrophy modelled in patient-derived human induced pluripotent stem cells 2015 ·Scientific Reports ·Emi Shoji, Hidetoshi Sakurai, (unknown), Tatsutoshi Nakahata, Toshio Heike, Tomonari Awaya, Nobuharu Fujii, Yasuko Manabe, Masafumi Matsuo, Atsuko Sehara‐Fujisawa	90
5	Efficient and Reproducible Myogenic Differentiation from Human iPS Cells: Prospects for Modeling Miyoshi Myopathy In Vitro 2013 ·PLoS ONE ·Akihito Tanaka, Knut Woltjen, Katsuya Miyake, Akitsu Hotta, Makoto Ikeya, Takuya Yamamoto, (unknown), Emi Shoji, Atsuko Sehara‐Fujisawa, Yasuko Manabe, Nobuharu Fujii, Kazunori Hanaoka, Takumi Era, Satoshi Yamashita, Ken‐ichi Isobe, En Kimura, Hidetoshi Sakurai	184
6	Correction: Efficient and Reproducible Myogenic Differentiation from Human iPS Cells: Prospects for Modeling Miyoshi Myopathy In Vitro 2013 ·PLoS ONE ·Akihito Tanaka, Knut Woltjen, Katsuya Miyake, Akitsu Hotta, Makoto Ikeya, Takuya Yamamoto, (unknown), Emi Shoji, Atsuko Sehara‐Fujisawa, Yasuko Manabe, Nobuharu Fujii, Kazunori Hanaoka, Takumi Era, Satoshi Yamashita, Ken‐ichi Isobe, En Kimura, Hidetoshi Sakurai	47
7	In Vitro Modeling of Paraxial Mesodermal Progenitors Derived from Induced Pluripotent Stem Cells 2012 ·PLoS ONE ·Hidetoshi Sakurai, (unknown), Emi Shoji, (unknown), (unknown), Hiroshi Sakai, Kazunori Hanaoka, Akira Kakizuka, Atsuko Sehara‐Fujisawa	46
8	A Novel Human CC Chemokine, Eotaxin-3, Which Is Expressed in IL-4-Stimulated Vascular Endothelial Cells, Exhibits Potent Activity Toward Eosinophils 1999 ·The Journal of Immunology ·Akeo Shinkai, Hajime Yoshisue, Masamichi Koike, Emi Shoji, Satoshi Nakagawa, Akiko Saito, Tsuyoshi Takeda, (unknown), Yuzuru Kato, Nobuo Hanai, Hideharu Anazawa, Tetsurō Kuga, Tatsunari Nishi	228

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact